ACTIVE SESSION TAPE Biotechnology $28M Cap Quant: AVOID NEW MONEY

Why Is Boundless Bio, Inc. (BOLD) Stock Down Today?

Updated Nov 22, 2026 6:14 AM ET ยท Prev Close $2.38

Pro Workspace
Last Session Price
$2.32 -2.52%
-$0.06 vs $2.38 prior close
Intraday Range
$2.28 โ€“ $2.38
Open $2.35
Relative Volume
1.55x Avg
146,418 sh
52-Week Range
$0.96 โ€“ $3.16
Benchmark Alpha
+1.12% vs SPY
+3.15% vs QQQ
20-Session Trend -3.7%

Session Regime & Catalyst Assessment

68% Signal Conviction
SECTOR 68% Driver Weight

Boundless Bio, Inc. Pulling Back 2.52% on 1.55x Relative Volume

Boundless Bio, Inc. (BOLD) is pulling back 2.52% (-$0.06) to $2.32 on 1.55x average session volume. Relative to benchmarks, BOLD is outperforming the S&P 500 by +1.12%. 14-day RSI stands at 35.0, keeping momentum in a bearish regime.

NEWS 70% Weight
Why Did Bold, Blze, Qnt Stocks Surge To 52-Week Highs Today

Investors showed interest in businesses tied to artificial intelligence infrastructure, advanced biotechnology, and quantum computing.

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($2.32) trades relative to 20-day SMA ($2.43) and 50-day SMA ($2.52).

Volume Confirmation
HIGH VOLUME (1.55x) Distribution
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

BOLD outperforming the S&P 500 by +1.12%
BOLD Session
-2.52%
$2.32
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +1.12% Alpha vs QQQ: +3.15% Alpha vs XLV: -2.40%

Recent BOLD Catalyst Headlines

Verified Wire

1โ€“3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$2.20
Short-term support band
Upper Bound
$2.44
Short-term resistance band
Key Inflection Level
$2.43 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $2.43 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (BOLD)

BEARISH MA TREND
RSI (14)
35.0
Bearish
20-Day SMA
$2.43
Below 20d
50-Day SMA
$2.52
Below 50d
MACD Signal
Bearish
MACD -0.04
ADX (14)
18.8
Weak trend
10d Momentum
-0.14
Soft 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.1
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Bullish sentiment dominates $BOLD on StockTwits with no new articles on Yahoo Finance.

Reddit communities: 1 comment (Neutral)

About Boundless Bio, Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, Bbi-355, is a novel, oral, selective inhibitor of โ€ฆ

Sector
Healthcare
Market Cap
$28M
Employees
64

Get Instant BOLD Catalyst Alerts

Receive an email alert when BOLD triggers an unusual volume breakout, options sweep, or rating shift.

BOLD Session & Catalyst FAQ

Why is BOLD stock down today?

Boundless Bio, Inc. (BOLD) is pulling back 2.52% (-$0.06) to $2.32 on 1.55x average session volume. Relative to benchmarks, BOLD is outperforming the S&P 500 by +1.12%. 14-day RSI stands at 35.0, keeping momentum in a bearish regime.

Is BOLD stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.55x relative volume (high participation). Our multi-factor model currently rates BOLD as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the BOLD Buy or Sell Decision Brief โ†’

What is BOLD's intrinsic value and expected trading range?

At $2.32, BOLD's modeled 1-to-3 session range is $2.20 โ€“ $2.44, with a key inflection level at $2.43 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the BOLD Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for BOLD?

RSI at 35.0 reflects soft below-midline momentum. BOLD trades at $2.32 relative to its 20-day SMA ($2.43) and 50-day SMA ($2.52), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs